{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:24:42Z","timestamp":1767835482419,"version":"3.49.0"},"reference-count":25,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The risk of developing severe complications from an influenza virus infection is increased in patients with chronic inflammatory diseases such as psoriasis (PsO) and atopic dermatitis (AD). However, low influenza vaccination rates have been reported. The aim of this study was to determine vaccination rates in PsO compared to AD patients and explore patient perceptions of vaccination. A multicenter cross-sectional study was performed in 327 and 98 adult patients with PsO and AD, respectively. Data on vaccination, patient and disease characteristics, comorbidity, and patient perceptions was collected with a questionnaire. Medical records and vaccination certificates were reviewed. A total of 49.8% of PsO and 32.7% of AD patients were vaccinated at some point, while in season 2018\/2019, 30.9% and 13.3% received an influenza vaccination, respectively. There were 96.6% and 77.6% of PsO and AD patients who had an indication for influenza vaccination due to age, immunosuppressive therapy, comorbidity, occupation, and\/or pregnancy. Multivariate regression analysis revealed higher age (p &lt; 0.001) and a history of bronchitis (p = 0.023) as significant predictors of influenza vaccination in PsO patients. Considering that most patients had an indication for influenza vaccination, the rate of vaccinated patients was inadequately low.<\/jats:p>","DOI":"10.3390\/vaccines9080843","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T21:46:44Z","timestamp":1627854404000},"page":"843","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Influenza Vaccination in Psoriatic Patients\u2014Epidemiology and Patient Perceptions: A German Multicenter Study (Vac-Pso)"],"prefix":"10.3390","volume":"9","author":[{"given":"Christian","family":"Kromer","sequence":"first","affiliation":[{"name":"Department of Dermatology, University Medical Center G\u00f6ttingen, 37075 G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phoebe","family":"Wellmann","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of G\u00f6ttingen, 37073 G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Siemer","sequence":"additional","affiliation":[{"name":"Faculty of Mathematics and Computer Science, University of G\u00f6ttingen, 37073 G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selina","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, University Bonn, 53127 Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Mohr","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Medical Center G\u00f6ttingen, 37075 G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1330-1502","authenticated-orcid":false,"given":"Andreas","family":"Pinter","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, University of Frankfurt, 60590 Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Wilsmann-Theis","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, University Bonn, 53127 Bonn, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotraut","family":"M\u00f6ssner","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Medical Center G\u00f6ttingen, 37075 G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/irv.12504","article-title":"Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis","volume":"12","author":"Coleman","year":"2018","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","article-title":"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2020\u20132021 Influenza Season","volume":"69","author":"Grohskopf","year":"2020","journal-title":"MMWR Recomm. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.amjmed.2007.10.040","article-title":"Complications of viral influenza","volume":"121","author":"Rothberg","year":"2008","journal-title":"Am. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1542\/peds.2012-1255","article-title":"The burden of influenza in young children, 2004\u20132009","volume":"131","author":"Poehling","year":"2013","journal-title":"Pediatrics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/rheumatology\/keq183","article-title":"Vaccinations in patients with immune-mediated inflammatory diseases","volume":"49","author":"Rahier","year":"2010","journal-title":"Rheumatology"},{"key":"ref_6","unstructured":"(2018). St\u00e4ndige Impfkommission: Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiol. Bull., 34, 355\u2013382."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/jdv.17220","article-title":"Quality of psoriasis care in Germany\u2014Results from the nationwide health care studies PsoHealth 2004\u20132017","volume":"35","author":"Langenbruch","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00403-012-1214-8","article-title":"German S3-guidelines on the treatment of psoriasis vulgaris (short version)","volume":"304","author":"Nast","year":"2012","journal-title":"Arch. Dermatol. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kao, L.T., Lee, C.Z., Liu, S.P., Tsai, M.C., and Lin, H.C. (2014). Psoriasis and the risk of pneumonia: A population-based study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0116077"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.jid.2018.01.039","article-title":"Risk of Serious Infection, Opportunistic Infection, and Herpes Zoster among Patients with Psoriasis in the United Kingdom","volume":"138","author":"Takeshita","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jaad.2010.08.036","article-title":"Increased risk of infectious disease requiring hospitalization among patients with psoriasis: A population-based cohort","volume":"65","author":"Wakkee","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_13","first-page":"19","article-title":"St\u00e4ndige Impfkommission: Wissenschaftliche Begr\u00fcndung f\u00fcr die Empfehlung des quadrivalenten saisonalen Influenzaimpfstoffs","volume":"2","author":"Falkenhorst","year":"2018","journal-title":"Epidemiol. Bull."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00103-019-02905-1","article-title":"Impfen bei Immundefizienz: Anwendungshinweise zu den von der Standigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzundlichen Erkrankungen und unter immunmodulatorischer Therapie","volume":"62","author":"Wagner","year":"2019","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10067-020-05059-7","article-title":"Understanding factors associated with vaccine uptake and vaccine hesitancy in patients with rheumatoid arthritis: A scoping literature review","volume":"40","author":"Boucher","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_16","first-page":"837","article-title":"Influenza vaccination rate among patients with moderate to severe psoriasis","volume":"11","author":"Radtke","year":"2013","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/1756-185X.13971","article-title":"Identifying perceptions and barriers regarding vaccination in patients with rheumatoid arthritis: A Canadian perspective","volume":"23","author":"Aberumand","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1080\/21645515.2020.1816108","article-title":"Knowledge and attitudes about influenza vaccination in rheumatic diseases patients","volume":"17","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"(2013). Chapter 1: Definition and classification of CKD. Kidney Int. Suppl., 3, 19\u201362.","DOI":"10.1038\/kisup.2012.64"},{"key":"ref_21","first-page":"845","article-title":"Vaccination coverage in German adults: Results of the German Health Interview and Examination Survey for Adults (DEGS1)","volume":"56","author":"Schmitz","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"ref_22","first-page":"3","article-title":"Impfquoten bei Erwachsenen in Deutschland\u2014Aktuelles aus der KV-Impfsurveillance und der Onlinebefragung von Krankenhauspersonal OKaPII","volume":"47","author":"Rieck","year":"2020","journal-title":"Epid. Bull."},{"key":"ref_23","unstructured":"(2019). World Health Ordganization Influenza Vaccines: WHO Position Paper. Wkly. Epidemiol. Rec., 80, 277\u2013288."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jid.2018.09.012","article-title":"Influenza Vaccination Rates in Adults with Psoriasis Compared to Adults with Other Chronic Diseases","volume":"139","author":"Noe","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"258430","DOI":"10.1155\/2015\/258430","article-title":"Possible Triggering Effect of Influenza Vaccination on Psoriasis","volume":"2015","author":"Gunes","year":"2015","journal-title":"J. Immunol. Res."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/8\/843\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:38:41Z","timestamp":1760164721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/8\/843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["vaccines9080843"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9080843","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}